Concepedia

Violeta Sánchez

VS

Statistics

Publications

54

Citations

7.5K

H-Index

39

Active since

2009

Affiliations

Vanderbilt University(Current)

Vanderbilt University Medical Center

Breast Cancer Research Foundation

Dana-Farber Cancer Institute

University of North Carolina at Chapel Hill

Violeta Sánchez is an author at Vanderbilt University specializing in oncology, medicine, and molecular oncology.

Publications per year

2009–2024

54

Publications

54

MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation

Kyung‐min Lee, Jennifer M. Giltnane, Justin M. Balko et al. · Cell Metabolism · 2017 · 646 citations · Full text

Medicine, Cell Biology, Oncology +12

TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer

Neil E. Bhola, Justin M. Balko, Teresa C. Dugger et al. · Journal of Clinical Investigation · 2013 · 593 citations · Full text

Medicine, Oncology, Pharmacology +17

Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

Douglas B. Johnson, Mónica V. Estrada, Roberto Salgado et al. · Nature Communications · 2016 · 572 citations · Full text

Life Sciences, Immunology, Oncology +17

RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors

Sherene Loi, Sathana Dushyanthen, Paul A. Beavis et al. · Clinical Cancer Research · 2015 · 552 citations · Full text

Medicine, Immunology, Oncology +17

Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets

Justin M. Balko, Jennifer M. Giltnane, Kai Wang et al. · Cancer Discovery · 2013 · 477 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–5 of 54